Cargando…
Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience
PURPOSE: Living-donor liver transplant emerged as an alternative treatment for end stage liver disease due to the lack of cadaveric organs availability that met the demand. In Portugal, pediatric living-donor liver transplant (P-LDLT) was initiated in 2001 in Portugal in order to compensate for the...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593358/ https://www.ncbi.nlm.nih.gov/pubmed/34796097 http://dx.doi.org/10.5223/pghn.2021.24.6.528 |
_version_ | 1784599719975059456 |
---|---|
author | dos Santos, José Pedro Fernandes Martins, Ricardo Lopes, Maria Francelina |
author_facet | dos Santos, José Pedro Fernandes Martins, Ricardo Lopes, Maria Francelina |
author_sort | dos Santos, José Pedro Fernandes |
collection | PubMed |
description | PURPOSE: Living-donor liver transplant emerged as an alternative treatment for end stage liver disease due to the lack of cadaveric organs availability that met the demand. In Portugal, pediatric living-donor liver transplant (P-LDLT) was initiated in 2001 in Portugal in order to compensate for the scarcity of cadaveric organs for such cases. The aim of this study was to retrospectively analyze the morbi-mortality of the 28 donors included in P-LDLT program performed at Coimbra's Pediatric Hospital (CHUC), a Portuguese reference center. METHODS: We retrospectively collected pertinent donor data and stratified complications according to Clavien's scoring system. RESULTS: In total, 28.6% (n=8) of the donors had surgical complications. According to Clavien-Dindo's classification, two donors had major complications (Clavien grade ≥3), four donors had grade 2 complications, and two donors had grade 1 complications. There were no P-LDLT-related mortalities in the present case series. The most common verified complications were biliary tract injuries and superficial incisional infections, which are consistent with the complications reported in worldwide series. CONCLUSION: These patients from CHUC shows that donor hepatectomy in P-LDLT is a safe procedure, with low morbidity and without mortality. |
format | Online Article Text |
id | pubmed-8593358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition |
record_format | MEDLINE/PubMed |
spelling | pubmed-85933582021-11-17 Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience dos Santos, José Pedro Fernandes Martins, Ricardo Lopes, Maria Francelina Pediatr Gastroenterol Hepatol Nutr Original Article PURPOSE: Living-donor liver transplant emerged as an alternative treatment for end stage liver disease due to the lack of cadaveric organs availability that met the demand. In Portugal, pediatric living-donor liver transplant (P-LDLT) was initiated in 2001 in Portugal in order to compensate for the scarcity of cadaveric organs for such cases. The aim of this study was to retrospectively analyze the morbi-mortality of the 28 donors included in P-LDLT program performed at Coimbra's Pediatric Hospital (CHUC), a Portuguese reference center. METHODS: We retrospectively collected pertinent donor data and stratified complications according to Clavien's scoring system. RESULTS: In total, 28.6% (n=8) of the donors had surgical complications. According to Clavien-Dindo's classification, two donors had major complications (Clavien grade ≥3), four donors had grade 2 complications, and two donors had grade 1 complications. There were no P-LDLT-related mortalities in the present case series. The most common verified complications were biliary tract injuries and superficial incisional infections, which are consistent with the complications reported in worldwide series. CONCLUSION: These patients from CHUC shows that donor hepatectomy in P-LDLT is a safe procedure, with low morbidity and without mortality. The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2021-11 2021-11-05 /pmc/articles/PMC8593358/ /pubmed/34796097 http://dx.doi.org/10.5223/pghn.2021.24.6.528 Text en Copyright © 2021 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article dos Santos, José Pedro Fernandes Martins, Ricardo Lopes, Maria Francelina Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience |
title | Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience |
title_full | Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience |
title_fullStr | Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience |
title_full_unstemmed | Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience |
title_short | Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience |
title_sort | donor surgical morbidity in pediatric living-donor liver transplant: a portuguese experience |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593358/ https://www.ncbi.nlm.nih.gov/pubmed/34796097 http://dx.doi.org/10.5223/pghn.2021.24.6.528 |
work_keys_str_mv | AT dossantosjosepedrofernandes donorsurgicalmorbidityinpediatriclivingdonorlivertransplantaportugueseexperience AT martinsricardo donorsurgicalmorbidityinpediatriclivingdonorlivertransplantaportugueseexperience AT lopesmariafrancelina donorsurgicalmorbidityinpediatriclivingdonorlivertransplantaportugueseexperience |